Literature DB >> 12498336

Effects of triazolam, 8-OH-DPAT, and buspirone on repeated acquisition in squirrel monkeys.

Peter J Winsauer1, Marcus S Delatte, Michael W Stevenson, Joseph M Moerschbaecher.   

Abstract

The nonserotonergic benzodiazepine, triazolam, was compared with two 5-HT1A receptor agonists, 8-OH-DPAT and buspirone, in squirrel monkeys responding under a repeated-acquisition procedure. In each session, subjects acquired a 4-response sequence by responding sequentially on 3 keys in the presence of 4 discriminative stimuli (colors). Response sequences for each session were maintained by food presentation under a second-order fixed-ratio schedule. Errors produced a brief time-out but did not reset the sequence. In general, all of the drugs produced dose-dependent decreases in overall response rate and increases in the percentage of errors as the cumulative dose was increased. Together, these results indicate that 5-HT1A receptor agonists disrupt learning in squirrel monkeys by producing rate-decreasing and error-increasing effects in a manner comparable with the nonserotonergic benzodiazepine triazolam.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12498336     DOI: 10.1037//1064-1297.10.4.392

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  2 in total

1.  Effects of GABA modulators on the repeated acquisition of response sequences in squirrel monkeys.

Authors:  Una C Campbell; Peter J Winsauer; Michael W Stevenson; Joseph M Moerschbaecher
Journal:  J Exp Anal Behav       Date:  2004-07       Impact factor: 2.468

2.  Tolerance to chronic delta-9-tetrahydrocannabinol (Δ⁹-THC) in rhesus macaques infected with simian immunodeficiency virus.

Authors:  Peter J Winsauer; Patricia E Molina; Angela M Amedee; Catalin M Filipeanu; Robin R McGoey; Dana A Troxclair; Edith M Walker; Leslie L Birke; Curtis Vande Stouwe; Jessica M Howard; Stuart T Leonard; Joseph M Moerschbaecher; Peter B Lewis
Journal:  Exp Clin Psychopharmacol       Date:  2011-04       Impact factor: 3.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.